Legend Biotech (LEGN) Current Assets (2019 - 2026)
Legend Biotech's (LEGN) quarterly Current Assets came in at $1.1 billion in Q1 2026, down 11.17% YoY from $1.2 billion in Q1 2025, and down 13.18% on a QoQ basis from $1.2 billion in Q4 2025.
Legend Biotech (LEGN) Current Assets (2019 - 2026) Analysis & Trends
Legend Biotech (LEGN) has 8 years of Current Assets data on file, last reported at $1.1 billion in Q1 2026.
- Quarterly Current Assets fell 11.17% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 11.17% YoY) and the FY2025 annual result came in at $1.2 billion, down 2.87% from the prior year.
- Current Assets fell to $1.1 billion in Q1 2026, from $1.2 billion in the prior quarter.
- In the past five years, Current Assets ranged from a high of $1.6 billion in Q2 2023 to a low of $864.4 million in Q1 2022.
- A 5-year average of $1.3 billion and a median of $1.2 billion in 2025 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets surged 181849.97% — and 2024, when it slipped 14.28%.
- Tracing LEGN's Current Assets over 5 years: stood at $1.1 billion in 2022, then jumped by 36.27% to $1.5 billion in 2023, then slipped by 14.28% to $1.3 billion in 2024, then dropped by 2.87% to $1.2 billion in 2025, then dropped by 13.18% to $1.1 billion in 2026.
- The last three Current Assets figures came in at $1.1 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | 1.23 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.23 Bn |
| Mar 31, 2026 | 1.08 Bn |
| Dec 31, 2025 | 1.25 Bn |
| Sep 30, 2025 | 1.24 Bn |
| Jun 30, 2025 | 1.25 Bn |
| Mar 31, 2025 | 1.22 Bn |
| Dec 31, 2024 | 1.28 Bn |
| Sep 30, 2024 | 1.35 Bn |
| Jun 30, 2024 | 1.42 Bn |
| Mar 31, 2024 | 1.41 Bn |
| Dec 31, 2023 | 1.50 Bn |
| Sep 30, 2023 | 1.51 Bn |
| Jun 30, 2023 | 1.61 Bn |
| Mar 31, 2023 | 915.40 Mn |
| Dec 31, 2022 | 1.10 Bn |
| Mar 31, 2022 | 864.40 Mn |
| Dec 31, 2021 | 949.85 Mn |
| Sep 30, 2021 | 653.36 Mn |
| Jun 30, 2021 | 720.83 Mn |
| Mar 31, 2021 | 475,074.00 |